End tidal CO2 tension: Pulmonary arterial hypertension vs pulmonary venous hypertension and response to treatment

Chest

Volumn 140, Issue 5, 2011, Pages 1267-1273

  Hemnes, Anna R ^a   Pugh, Meredith E ^a   Newman, Alexander L ^a   Robbins, Ivan M ^a   Tolle, James ^a   Austin, Eric D ^b   Newman, John H ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTACYCLIN; PROSTAGLANDIN; UNIPROST;

ADULT; ARTICLE; BREATHING; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIASTOLIC BLOOD PRESSURE; DIFFERENTIAL DIAGNOSIS; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG RESPONSE; END TIDAL CARBON DIOXIDE TENSION; FEMALE; HEART CATHETERIZATION; HEART LEFT VENTRICLE FAILURE; HUMAN; LUNG ARTERY PRESSURE; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY ARTERY OCCLUSION PRESSURE; PULMONARY HYPERTENSION; PULMONARY VASCULAR DISEASE; PULMONARY VENOUS HYPERTENSION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SYSTOLIC DYSFUNCTION; WALKING;

EID: 81055157360     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-0155     Document Type: Article

References (21)

1. McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol. 2009;53(17):1573-1619.
2. Hemnes AR, Forfia PR, Champion HC. Assessment of pulmonary vasculature and right heart by invasive haemodynamics and echocardiography. Int J Clin Pract Suppl. 2009;63(suppl s162):4-19.
3. Badesch DB, Champion HC, Sanchez MA, et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol. 2009;54(suppl 1):S55-S66.
4. Arkles JS, Opotowsky AR, Ojeda J, et al. Shape of the right ventricular Doppler envelope predicts hemodynamics and right heart function in pulmonary hypertension. Am J Respir Crit Care Med. 2011;183(2):268-276.
5. Peacock A, Keogh A, Humbert M. Endpoints in pulmonary arterial hypertension: the role of clinical worsening. Curr Opin Pulm Med. 2010;16(suppl 1):S1-S9.
6. Pietra GG, Capron F, Stewart S, et al. Pathologic assessment of vasculopathies in pulmonary hypertension. J Am Coll Cardiol. 2004;43(12 suppl 1):25S-32S. (Pubitemid 38759714)
7. Yasunobu Y, Oudiz RJ, Sun XG, et al. End-tidal PCO2 abnormality and exercise limitation in patients with primary pulmonary hypertension. Chest. 2005;127(5):1637-1646. (Pubitemid 46218789)
8. Methvin AB, Owens AT, Emmi AG, et al. Ventilatory inefficiency reflects right ventricular dysfunction in systolic heart failure. Chest. 2011;139(3):617-625.
9. Matsumoto A, Itoh H, Eto Y, et al. End-tidal CO2 pressure decreases during exercise in cardiac patients: association with severity of heart failure and cardiac output reserve. J Am Coll Cardiol. 2000;36(1):242-249. (Pubitemid 30466140)
10. Tanabe Y, Hosaka Y, Ito M, Ito E, Susuki K. Significance of end-tidal P(CO(2)) response to exercise and its relation to functional capacity in patients with chronic heart failure. Chest. 2001;119(3):811-817. (Pubitemid 32197653)
11. Hansen JE, Ulubay G, Chow BF, Sun XG, Wasserman K. Mixed-expired and end-tidal CO2 distinguish between ventilation and perfusion defects during exercise testing in patients with lung and heart diseases. Chest. 2007;132(3):977-983.
12. Hemnes AR, Newman AL, Rosenbaum B, et al. Bedside endtidal CO2 tension as a screening tool to exclude pulmonary embolism. Eur Respir J. 2010;35(4):735-741.
13. Wilson RF, Beckman SB, Tyburski JG, Scholten DJ. Pulmonary artery diastolic and wedge pressure relationships in critically ill and injured patients. Arch Surg. 1988;123(8):933-936.
14. Her C, Cerabona T, Baek SH, Shin SW. Increased pulmonary venous resistance in morbidly obese patients without daytime hypoxia: clinical utility of the pulmonary artery catheter. Anesthesiology. 2010;113(3):552-559.
15. Lappas D, Lell WA, Gabel JC, Civetta JM, Lowenstein E. Indirect measurement of left-atrial pressure in surgical patients-pulmonary-capillary wedge and pulmonary-artery diastolic pressures compared with left-atrial pressure. Anesthesiology.1973;38(4):394-397.
16. Robbins IM, Newman JH, Johnson RF, et al. Association of the metabolic syndrome with pulmonary venous hypertension. Chest. 2009;136(1):31-36.
17. Operators Manual. NPB 75: Portable Bedside Capnograph/Pulse Oximeter. Pleasanton, CA: Nellcor Puritan Bennet; 1998.
18. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111-117.
19. Provencher S, Sitbon O, Humbert M, Cabrol S, Jaïs X, Simonneau G. Long-term outcome with first-line bosentan therapy in idiopathic pulmonary arterial hypertension. Eur Heart J. 2006;27(5):589-595.
20. Oudiz RJ, Barst RJ, Hansen JE, et al. Cardiopulmonary exercise testing and six-minute walk correlations in pulmonary arterial hypertension. Am J Cardiol. 2006;97(1):123-126. (Pubitemid 41828135)
21. Hyduk A, Croft JB, Ayala C, Zheng K, Zheng ZJ, Mensah GA. Pulmonary hypertension surveillance-United States, 1980-2002. MMWR Surveill Summ. 2005;54(5):1-28.